10-[(E)-[(7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione;10-[(E)-[(7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione

C71H98N6O6 — CID 158362929

IUPAC10-[(E)-[(7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione;10-[(E)-[(7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione
SMILESCC(C)CCC[C@@H](C)C1CCC2/C(=C/C3C4=C(CC(O)CC4)Cn4c(=O)n(-c5ccccc5)c(=O)n43)CCC[C@@]21C.CC(C)[C@@H](C)/C=C/[C@@H](C)C1CCC2/C(=C/C3C4=C(CC(O)CC4)Cn4c(=O)n(-c5ccccc5)c(=O)n43)CCC[C@@]21C
InChIInChI=1S/C36H49N3O3.C35H49N3O3/c1-23(2)24(3)13-14-25(4)31-17-18-32-26(10-9-19-36(31,32)5)21-33-30-16-15-29(40)20-27(30)22-37-34(41)38(35(42)39(33)37)28-11-7-6-8-12-28;1-23(2)10-8-11-24(3)30-17-18-31-25(12-9-19-35(30,31)4)21-32-29-16-15-28(39)20-26(29)22-36-33(40)37(34(41)38(32)36)27-13-6-5-7-14-27/h6-8,11-14,21,23-25,29,31-33,40H,9-10,15-20,22H2,1-5H3;5-7,13-14,21,23-24,28,30-32,39H,8-12,15-20,22H2,1-4H3/b14-13+,26-21+;25-21+/t24-,25+,29?,31?,32?,33?,36+;24-,28?,30?,31?,32?,35-/m01/s1
InChIKeyGTRMEWFUFMNLCN-NCXPJEEPSA-N
MW1131.60 g/mol
LogP13.63
Rot. Bonds13

About 10-[(E)-[(7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione;10-[(E)-[(7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione

10-[(E)-[(7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione;10-[(E)-[(7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione (PubChem CID 158362929) has the molecular formula C71H98N6O6 and a molecular weight of 1131.60 g/mol. Its IUPAC name is 10-[(E)-[(7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione;10-[(E)-[(7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione.

Molecular Properties

Compound Name10-[(E)-[(7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione;10-[(E)-[(7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione
PubChem CID158362929
Molecular FormulaC71H98N6O6
Molecular Weight1131.60 g/mol
Exact Mass1130.75
IUPAC Name10-[(E)-[(7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione;10-[(E)-[(7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione
SMILESCC(C)CCC[C@@H](C)C1CCC2/C(=C/C3C4=C(CC(O)CC4)Cn4c(=O)n(-c5ccccc5)c(=O)n43)CCC[C@@]21C.CC(C)[C@@H](C)/C=C/[C@@H](C)C1CCC2/C(=C/C3C4=C(CC(O)CC4)Cn4c(=O)n(-c5ccccc5)c(=O)n43)CCC[C@@]21C
InChIInChI=1S/C36H49N3O3.C35H49N3O3/c1-23(2)24(3)13-14-25(4)31-17-18-32-26(10-9-19-36(31,32)5)21-33-30-16-15-29(40)20-27(30)22-37-34(41)38(35(42)39(33)37)28-11-7-6-8-12-28;1-23(2)10-8-11-24(3)30-17-18-31-25(12-9-19-35(30,31)4)21-32-29-16-15-28(39)20-26(29)22-36-33(40)37(34(41)38(32)36)27-13-6-5-7-14-27/h6-8,11-14,21,23-25,29,31-33,40H,9-10,15-20,22H2,1-5H3;5-7,13-14,21,23-24,28,30-32,39H,8-12,15-20,22H2,1-4H3/b14-13+,26-21+;25-21+/t24-,25+,29?,31?,32?,33?,36+;24-,28?,30?,31?,32?,35-/m01/s1
InChIKeyGTRMEWFUFMNLCN-NCXPJEEPSA-N
XLogP13.63
TPSA138.32 Ų
H-Bond Donors2
H-Bond Acceptors12
Rotatable Bonds13
Heavy Atoms83
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001131.60
LogP ≤ 513.63
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 10-[(E)-[(7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione;10-[(E)-[(7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 10-[(E)-[(7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione;10-[(E)-[(7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione?
The IUPAC name of 10-[(E)-[(7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione;10-[(E)-[(7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione (CID 158362929) is 10-[(E)-[(7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione;10-[(E)-[(7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione.
What is the SMILES notation for 10-[(E)-[(7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione;10-[(E)-[(7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione?
The canonical SMILES for 10-[(E)-[(7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione;10-[(E)-[(7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione is CC(C)CCC[C@@H](C)C1CCC2/C(=C/C3C4=C(CC(O)CC4)Cn4c(=O)n(-c5ccccc5)c(=O)n43)CCC[C@@]21C.CC(C)[C@@H](C)/C=C/[C@@H](C)C1CCC2/C(=C/C3C4=C(CC(O)CC4)Cn4c(=O)n(-c5ccccc5)c(=O)n43)CCC[C@@]21C.
What is the InChIKey of 10-[(E)-[(7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione;10-[(E)-[(7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione?
The InChIKey is GTRMEWFUFMNLCN-NCXPJEEPSA-N. The full InChI is InChI=1S/C36H49N3O3.C35H49N3O3/c1-23(2)24(3)13-14-25(4)31-17-18-32-26(10-9-19-36(31,32)5)21-33-30-16-15-29(40)20-27(30)22-37-34(41)38(35(42)39(33)37)28-11-7-6-8-12-28;1-23(2)10-8-11-24(3)30-17-18-31-25(12-9-19-35(30,31)4)21-32-29-16-15-28(39)20-26(29)22-36-33(40)37(34(41)38(32)36)27-13-6-5-7-14-27/h6-8,11-14,21,23-25,29,31-33,40H,9-10,15-20,22H2,1-5H3;5-7,13-14,21,23-24,28,30-32,39H,8-12,15-20,22H2,1-4H3/b14-13+,26-21+;25-21+/t24-,25+,29?,31?,32?,33?,36+;24-,28?,30?,31?,32?,35-/m01/s1.
What are the key properties of 10-[(E)-[(7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione;10-[(E)-[(7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione?
10-[(E)-[(7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione;10-[(E)-[(7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione has a molecular weight of 1131.60 g/mol, XLogP of 13.63, 13 rotatable bonds, 2 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 10-[(E)-[(7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione;10-[(E)-[(7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]methyl]-7-hydroxy-2-phenyl-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[1,2-b]phthalazine-1,3-dione is sourced from PubChem (CID 158362929), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).